Session Details
[P02]Poster 2 (5. Vaccine / Even Number)
Thu. Sep 11, 2025 1:30 PM - 2:30 PM JST
Thu. Sep 11, 2025 4:30 AM - 5:30 AM UTC
Thu. Sep 11, 2025 4:30 AM - 5:30 AM UTC
Poster(Reception Hall B)
[P080(ST1)]Preclinical study of PfRipr5 formulated with human-compatible adjuvants for blood-stage malaria vaccine development
○Eizo Takashima1, Hikaru Nagaoka1, Hidenori Kimura2, Akihisa Fukushima2, Takafumi Tsuboi3 (1. Division of Malaria Research, Proteo-Science Center, Ehime University (Japan), 2. Vaccines, Sumitomo Pharma (Japan), 3. Division of Cell-free Science, Proteo-Science Center, Ehime University (Japan))
[P082]Limited Hemagglutination-Inhibition Responses to a 2024 Quadrivalent Influenza Vaccine in Healthy Adults
○Kohei Tsujimoto1, Yutaka Muto1, Sumiyuki Nishida1, Atsushi Kumanogoh1 (1. Respiratory Medicine and Clinical Immunology, The University of Osaka (Japan))
[P084 (S06-04)]High-avidity antigen-specific CD4+T cells exhibit distinct, public and convergent TCR sequence features
○Dongyun Lu1,4, Celine Chua1,4, Xinxin Xue1,4, Naila Shinwari1,4, Isao Ito2, Takao Hashiguchi3, Hideki Ueno1,4 (1. Department of Immunology, Graduate School of Medicine, Kyoto University (Japan), 2. Department of Respiratory Medicine, Kyoto University Hospital (Japan), 3. Institute for Frontier Life and Medical Sciences, Kyoto University (Japan), 4. Kyoto Immunomonitoring Center (KIC) (Japan))
[P088]A multi-scale map of protein assemblies in the DNA damage response
○Anton Kratz1,3, Minkyu Kim2, Marcus R Kelly3, Fan Zheng3, Christopher R Koczor4, Jianfeng Li4, Keiichiro Ono3, Yue Qin3, Christopher Churas3, Jing Chen3, Rudolf T Pillich3, Jisoo Park3, Maya Modak2, Rachel Collier3, Kate Licon3, Dexter Pratt3, Robert W Sobol4, Nevan J Krogan2, Trey Ideker3 (1. Nagasaki University (Japan), 2. University of California San Francisco (United States of America), 3. University of California San Diego (United States of America), 4. University of South Alabama (United States of America))